Fundraising Fox

Arda Therapeutics

13 known investors

Find your way into Arda Therapeutics

1,163 people in our graph share verified history with the Arda Therapeutics team — schools, employers, funds. One of them is your warm intro.

Paul Kwanunlockedknows Adam Freund · together at Stanford University (overlapped)
×8knows the team · via Stanford University
knows the team · via On Deck
knows the team · via UC Berkeley
knows the team · via McGill University

Arda Therapeutics is a drug development company that uses single-cell computational biology to identify and eliminate pathogenic cells as a way to treat chronic diseases. It operates in the biotechnology and therapeutics sector.

AI & Machine LearningBiotechDigital HealthLongevityMedical Devices

Founders & leadership

AFAdam Freund
Adam FreundinFounder & Chief Executive OfficerAdam Freund holds a Ph.D. in molecular and cell biology and brings 18 years of experience in research and drug development across multiple therapeutic modalities including gene therapy, small molecule, large molecule, and cell therapy. He is the founder and CEO of Arda Therapeutics.
RLRemi-Martin Laberge
Remi-Martin LabergeinFounder & Chief Technology OfficerRemi-Martin Laberge is a cellular biologist with expertise in aging, fibrotic and inflammatory diseases, and oncology, with publications and patents in these areas. He founded Arda Therapeutics, where he serves as Chief Technology Officer.

Investors · 13

GV (Google Ventures)Mountain View · $250K – $50M
Alumni VenturesreportedManchester · $100K – $10M
Axial VCreportedSan Francisco · $100K – $5M
GaingelsreportedNew York · $200K – $500K
Indicator VenturesreportedNew York · $1M – $3M
Mana VenturesreportedEstero
Two Sigma Venturesreported · 2 sourcesNew York · $2M – $15M
Valhalla VenturesreportedNew York · $10M

Also in the syndicate · 5

Biovision VenturesEli Lilly and CompanyExitFundLifeLink VenturesRV Invest

Funding

SEC filings, press & company announcements

$43M disclosed across 1 round · 2024

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

2 people who came through Arda Therapeutics went on to found or lead other companies.

Adam FreundFounder & Chief Executive OfficerFounded Arda TherapeuticsRemi-Martin LabergeFounder & Chief Technology OfficerFounded Arda Therapeutics

In the news

Sell or Invest in Arda Therapeutics Stock Pre-IPOnasdaqprivatemarket.com · Oct 2025Arda Therapeutics: A New Approach to Targeting Disease at the Cellular Level | by Etienne C. | Life Sciences Funding News | Mediummedium.com · Oct 2024Arda Therapeutics Raises $43M in Series A Financingfinsmes.com · Oct 2024Arda Therapeutics Secures $43M Series A Financing to Advance Targeted Cell Depletion Therapies — Arda Therapeuticsardatx.com · Oct 2024Exclusive: Lilly backs a16z-funded Arda Therapeutics’ $43M Series A to take ADCs into fibrosisendpoints.news · Oct 2024Arda Therapeutics - $43M Early Stage Venture | Startup Introsstartupintros.com · Sep 2024

Frequently asked questions

What does Arda Therapeutics do?
Arda Therapeutics is a drug development company that uses single-cell computational biology to identify and eliminate pathogenic cells as a way to treat chronic diseases. It operates in the biotechnology and therapeutics sector.
Who founded Arda Therapeutics?
Arda Therapeutics was founded by Adam Freund, Remi-Martin Laberge.
Who are Arda Therapeutics's investors?
Arda Therapeutics's investors include GV (Google Ventures), Alumni Ventures, Axial VC, Gaingels, Indicator Ventures, Mana Ventures, Two Sigma Ventures, Valhalla Ventures.
How much funding has Arda Therapeutics raised?
Arda Therapeutics has disclosed $43M raised across 1 round.